adjuvant nivolumab in resected oesophageal or goj cancer following chemo
Published 1 year ago • 130 plays • Length 9:10Download video MP4
Download video MP3
Similar videos
-
8:16
nivolumab for oesophageal cancer following chemoradiation therapy
-
3:13
attraction-3: nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma
-
2:13
adjuvant nivolumab as soc for high-risk muscle-invasive urothelial carcinoma after radical resection
-
4:14
adjuvant nivolumab in patients with resected esophageal or gej cancer (checkmate 577)
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577
-
59:58
management of esophageal/gej cancers: an interdisciplinary tumor board on adjuvant immunotherapy
-
2:47
attraction-4: nivolumab plus chemotherapy for gastric or gastroesophageal cancer
-
5:18
checkmate577: nivolumab in ec/gejc
-
11:12
expert video report on immunotherapy in gastro oesophageal cancer from 2021 asco annual meeting
-
2:25
adjuvant therapy for esophageal cancer
-
31:33
oesophageal cancer | neo-adjuvant chemotherapy | neo-adjuvant chemo-radiotherapy | cancer treatment
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
3:08
adjuvant nivolumab after chemo-radiation for localized muscle-invasive bladder cancer
-
1:22
3-year follow-up of checkmate 649: nivolumab chemotherapy in gc/gejc/eac
-
10:45
new data on adjuvant treatment of esophageal cancer
-
13:47
checkmate 577 - is nivolumab adjuvant the standard of care in esophagus and gej?
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
2:26
attraction-5: nivo plus chemotherapy as postoperative adjuvant treatment for pstage iii g/gej cancer